These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 24100744

  • 21. Clinical grand rounds: atypical hemolytic uremic syndrome.
    Hodgkins KS, Bobrowski AE, Lane JC, Langman CB.
    Am J Nephrol; 2012; 35(5):394-400. PubMed ID: 22517061
    [Abstract] [Full Text] [Related]

  • 22. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
    Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD, Martino M, Sesta M, Di Cuonzo F, Resta MC, Gaeta A, Milella L, Chironna M, Germinario C, Scavia G, Gesualdo L, Giordano M.
    Pediatr Nephrol; 2019 Mar; 34(3):517-527. PubMed ID: 30362078
    [Abstract] [Full Text] [Related]

  • 23. Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.
    Salameh H, Abu Omar M, Alhariri A, Kisra S, Qasem A, Abdulhak AB.
    Am J Ther; 2016 Mar; 23(4):e1110-5. PubMed ID: 25486517
    [Abstract] [Full Text] [Related]

  • 24. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
    Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C.
    Kidney Int; 2016 Mar; 89(3):701-11. PubMed ID: 26880462
    [Abstract] [Full Text] [Related]

  • 25. Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis.
    Povey H, Vundru R, Junglee N, Jibani M.
    Clin Nephrol; 2014 Nov; 82(5):326-31. PubMed ID: 23557793
    [Abstract] [Full Text] [Related]

  • 26. Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings.
    Tschumi S, Gugger M, Bucher BS, Riedl M, Simonetti GD.
    Pediatr Nephrol; 2011 Nov; 26(11):2085-8. PubMed ID: 21877169
    [Abstract] [Full Text] [Related]

  • 27. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
    Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N.
    Intern Med J; 2015 Oct; 45(10):1054-65. PubMed ID: 26247170
    [Abstract] [Full Text] [Related]

  • 28. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa M, Grinyó JM, Praga M, Torra R, Vilalta R, Rodríguez de Córdoba S.
    Nefrologia; 2013 Jan 18; 33(1):27-45. PubMed ID: 23364625
    [Abstract] [Full Text] [Related]

  • 29. [Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].
    Fukasawa C, Ooishi S, Kumagai T, Koshiisi M, Sueki Y, Nakajima K, Mitsumori T, Yoshida Y, Kato H, Nangaku M, Miyata T, Kirito K.
    Rinsho Ketsueki; 2018 Jan 18; 59(2):182-186. PubMed ID: 29515071
    [Abstract] [Full Text] [Related]

  • 30. Hemolytic uremic syndrome in children.
    Talarico V, Aloe M, Monzani A, Miniero R, Bona G.
    Minerva Pediatr; 2016 Dec 18; 68(6):441-455. PubMed ID: 27768015
    [Abstract] [Full Text] [Related]

  • 31. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
    Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F.
    Pediatr Nephrol; 2013 Jan 18; 28(1):155-8. PubMed ID: 22956028
    [Abstract] [Full Text] [Related]

  • 32. Typical or Atypical Hemolytic Uremic Syndrome and the Use of Eculizumab: 4 Illustrative Cases.
    de Ville de Goyet M, Detaille T, Godefroid N.
    J Pediatr Hematol Oncol; 2019 Oct 18; 41(7):e459-e462. PubMed ID: 30933023
    [Abstract] [Full Text] [Related]

  • 33. [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].
    Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F.
    G Ital Nefrol; 2019 Apr 18; 36(2):. PubMed ID: 30983177
    [Abstract] [Full Text] [Related]

  • 34. Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome.
    Vilalta R, Lara E, Madrid A, Chocron S, Muñoz M, Casquero A, Nieto J.
    Pediatr Nephrol; 2012 Dec 18; 27(12):2323-6. PubMed ID: 22890512
    [Abstract] [Full Text] [Related]

  • 35. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
    Andries G, Karass M, Yandrapalli S, Linder K, Liu D, Nelson J, Pawar R, Chugh S.
    Exp Hematol Oncol; 2017 Dec 18; 6():4. PubMed ID: 28101432
    [Abstract] [Full Text] [Related]

  • 36. Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab.
    Webb TN, Griffiths H, Miyashita Y, Bhatt R, Jaffe R, Moritz M, Hofer J, Swiatecka-Urban A.
    Int J Med Pharm Case Reports; 2015 Dec 18; 4(5):105-112. PubMed ID: 27135055
    [Abstract] [Full Text] [Related]

  • 37. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E, Alberti M, Noris M.
    J Nephrol; 2012 Dec 18; 25(6):911-7. PubMed ID: 22760880
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
    Matar D, Naqvi F, Racusen LC, Carter-Monroe N, Montgomery RA, Alachkar N.
    Transplantation; 2014 Dec 15; 98(11):1205-12. PubMed ID: 24933457
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.